These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 4677065)

  • 1. Effect of sustained-release on the excretion of some metabolites of diethylopropion.
    Banci F; Cartoni GP; Cavalli A; Monai A
    Arzneimittelforschung; 1972 Oct; 22(10):1724-6. PubMed ID: 4677065
    [No Abstract]   [Full Text] [Related]  

  • 2. Bioavailability of amfepramone hydrochloride sustained release pellets formulation in healthy subjects.
    Dangor CM; Beckett AH; Veltman AM
    Arzneimittelforschung; 1987 Jun; 37(6):736-9. PubMed ID: 3663274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Excretion of some basic metabolites of diethylpropion in man and rabbit.
    Banci F; Cartoni GP; Cavalli A; Monai A
    Arzneimittelforschung; 1971 Oct; 21(10):1616-8. PubMed ID: 5171897
    [No Abstract]   [Full Text] [Related]  

  • 4. Re-evaluation of the metabolism and excretion of diethylpropion in non-sustained and sustained release formulations.
    Beckett AH; Stanojcić M
    J Pharm Pharmacol; 1987 Jun; 39(6):409-15. PubMed ID: 2886596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The metabolism of diethylpropion in man; influence of changes in drug formulation and urinary pH.
    Testa B; Beckett AH
    Pharm Acta Helv; 1974; 49(1):21-7. PubMed ID: 4854957
    [No Abstract]   [Full Text] [Related]  

  • 6. Controlled-release diethylpropion hydrochloride used in a program for weight reduction.
    Parsons WB
    Clin Ther; 1981; 3(5):329-35. PubMed ID: 7471128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A long-acting appetite suppressant drug studied for 24 weeks in both continuous and sequential administration.
    Le Riche WH; Csima A
    Can Med Assoc J; 1967 Oct; 97(17):1016-20. PubMed ID: 6052900
    [No Abstract]   [Full Text] [Related]  

  • 8. Lithium absorption from ordinary and from sustained-release tablets.
    Otto U; Paalzow L; Surén G
    Acta Pharm Suec; 1972 Dec; 9(6):595-601. PubMed ID: 4656566
    [No Abstract]   [Full Text] [Related]  

  • 9. Metabolism and excretion of diethylpropion in man under acidic urine conditions.
    Testa B; Beckett AH
    J Pharm Pharmacol; 1973 Feb; 25(2):119-24. PubMed ID: 4146542
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of absorption rate on the pre-systemic chiral inversion of ibuprofen in rabbits.
    Doki K; Hayakawa T; Lin W; Yanaguimoto H; Ding G; Inotsume N
    J Pharm Pharmacol; 2003 Aug; 55(8):1091-7. PubMed ID: 12956898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Faster clearance of sustained release verapamil in men versus women: continuing observations on sex-specific differences after oral administration of verapamil.
    Krecic-Shepard ME; Barnas CR; Slimko J; Schwartz JB
    Clin Pharmacol Ther; 2000 Sep; 68(3):286-92. PubMed ID: 11014410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Availability of phenformin in an oral sustained-release form].
    Bramanti G
    Boll Chim Farm; 1973 Jul; 112(7):472-8. PubMed ID: 4765108
    [No Abstract]   [Full Text] [Related]  

  • 13. Sustained release tablets for potassium chloride administration. A pharmacological study.
    Bervenmark H; Eriksson G; Ljungberg S; Paalzow L
    Acta Pharm Suec; 1966 Feb; 3(1):45-58. PubMed ID: 5909431
    [No Abstract]   [Full Text] [Related]  

  • 14. Animal models for predicting potency of oral sustained-release adhesive microspheres in humans.
    Nagahara N; Akiyama Y; Higaki K; Kimura T
    Int J Pharm; 2007 Feb; 331(1):46-53. PubMed ID: 17098383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the percutaneous absorption and metabolism of some aminopropiophenones.
    Markantonis SL; Kyroudis A; Beckett AH
    J Pharm Pharmacol; 1986 Jul; 38(7):515-9. PubMed ID: 2875152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potassium absorption from sustained release tablets.
    Graffner C; Sjögren J
    Acta Pharm Suec; 1971 Mar; 8(1):13-8. PubMed ID: 5575869
    [No Abstract]   [Full Text] [Related]  

  • 17. High-amylose carboxymethyl starch matrices for oral sustained drug-release: in vitro and in vivo evaluation.
    Nabais T; Brouillet F; Kyriacos S; Mroueh M; Amores da Silva P; Bataille B; Chebli C; Cartilier L
    Eur J Pharm Biopharm; 2007 Mar; 65(3):371-8. PubMed ID: 17275270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Some chemical and stereochemical aspects of diethylpropion metabolism in man.
    Testa B
    Acta Pharm Suec; 1973 Dec; 10(6):441-54. PubMed ID: 4773113
    [No Abstract]   [Full Text] [Related]  

  • 19. [Release, absorption and elimination of theophylline from fast and slowly released oral formulations].
    Frömming KH; Schwabe L; Staib AH; Rietbrock N; Lassmann A; Molz KH; Schuppan D; Siebert-Weigel M; Voegele D
    Arzneimittelforschung; 1983; 33(3):446-52. PubMed ID: 6683521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A pharmacokinetic investigation of the distribution and elimination of diethylpropion and its metabolites in man.
    Mihailova D; Rosen A; Testa B; Beckett AH
    J Pharm Pharmacol; 1974 Sep; 26(9):711-21. PubMed ID: 4155748
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.